Published in Am J Hum Genet on July 01, 1999
FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med (2001) 3.84
Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res (2011) 1.49
A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn (2009) 1.33
Longitudinal changes in intellectual development in children with Fragile X syndrome. J Abnorm Child Psychol (2008) 1.12
Video analysis of sensory-motor features in infants with fragile X syndrome at 9-12 months of age. J Autism Dev Disord (2005) 1.07
Modeling fragile X syndrome in the Fmr1 knockout mouse. Intractable Rare Dis Res (2014) 0.88
A quantitative homogeneous assay for fragile X mental retardation 1 protein. J Neurodev Disord (2013) 0.85
Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders. Genes (Basel) (2016) 0.75
Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP). Genes (Basel) (2016) 0.75
Recent advances in assays for the fragile X-related disorders. Hum Genet (2017) 0.75
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med (1991) 4.61
The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet (1993) 4.57
DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22
Prevalence of fragile X syndrome. Am J Med Genet (1996) 3.19
Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA (1993) 2.59
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature (1993) 2.36
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
Rapid antibody test for fragile X syndrome. Lancet (1995) 2.22
Lesch-Nyhan syndrome: rapid detection of heterozygotes by use of hair follicles. Science (1971) 1.64
Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet (1997) 1.59
Glucose-6 phosphate dehydrogenase mosaicism: utilization as a tracer in the study of the development of hair root cells. Ann Hum Genet (1969) 1.57
Mental status of females with an FMR1 gene full mutation. Am J Hum Genet (1996) 1.57
Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genet (1998) 1.52
Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet (1993) 1.30
Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet (1991) 1.23
Mosaicism in fragile X affected males. Am J Med Genet (1994) 1.23
The nucleotide sequence of chicken smooth muscle myosin light chain two. Nucleic Acids Res (1988) 1.16
Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet (1995) 0.92
Fabry's disease: biochemical and histochemical studies on hair roots for carrier detection. Br J Dermatol (1978) 0.86
The fragile X syndrome and other fragile site disorders. Results Probl Cell Differ (1998) 0.83
Evidence for the derivation of individual hair roots from three progenitor cells. Hum Genet (1981) 0.78
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
Work satisfaction of general practitioners and the quality of patient care. Fam Pract (1985) 3.78
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet (1993) 3.58
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J (1988) 2.44
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A (1982) 2.39
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature (1993) 2.36
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet (1999) 2.23
Rapid antibody test for fragile X syndrome. Lancet (1995) 2.22
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet (1994) 2.19
Distinct genetic forms of frontotemporal dementia. Neurology (2008) 2.15
Non-syndromic, autosomal-recessive deafness. Clin Genet (2006) 2.08
Quality judgements by patients on general practice care: a literature analysis. Soc Sci Med (1994) 2.08
The fragile X syndrome. J Med Genet (1998) 2.00
A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell (1990) 1.97
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene (2009) 1.96
Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2007) 1.93
ACE polymorphisms. Circ Res (2006) 1.92
Deletion loop mutagenesis: a novel method for the construction of point mutations using deletion mutants. Nucleic Acids Res (1982) 1.90
European experience with prenatal diagnosis of congenital disease: a survey of 6121 cases. Cytogenet Cell Genet (1976) 1.89
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia (2000) 1.80
Indicators of the quality of general practice care of patients with chronic illness: a step towards the real involvement of patients in the assessment of the quality of care. Qual Health Care (1996) 1.79
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet (1999) 1.76
Familial aggregation in frontotemporal dementia. Neurology (1998) 1.76
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes (2001) 1.76
Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet (1997) 1.74
Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell (1988) 1.73
Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res (2000) 1.73
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet (2001) 1.71
CGG repeat in the FMR1 gene: size matters. Clin Genet (2011) 1.68
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology (2009) 1.68
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68
A new family with the Townes-Brocks syndrome. Clin Genet (1988) 1.66
CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet (1995) 1.64
Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63
Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet (1995) 1.63
Mitochondrial deafness. Clin Genet (2007) 1.61
Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61
Characterization and localization of the Huntington disease gene product. Hum Mol Genet (1993) 1.60
Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet (1997) 1.59
Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet (2000) 1.59
Estimating human age from T-cell DNA rearrangements. Curr Biol (2010) 1.58
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology (1993) 1.57
Mental status of females with an FMR1 gene full mutation. Am J Hum Genet (1996) 1.57
A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A). Clin Chim Acta (1990) 1.57
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet (1998) 1.54
Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet (1999) 1.53
Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet (2005) 1.52
Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature (1983) 1.52
Molecular dissection of a contiguous gene syndrome: localization of the genes involved in the Langer-Giedion syndrome. Hum Mol Genet (1995) 1.51
Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry (2010) 1.50
Risk factors for stroke-related pain 1 year after first-ever stroke. Eur J Neurol (2008) 1.50
Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet (1997) 1.49
FMRP is associated to the ribosomes via RNA. Hum Mol Genet (1996) 1.49
Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation. Am J Med Genet A (2003) 1.48
Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res (2006) 1.47
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology (2008) 1.45
Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet (1996) 1.45
Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. J Clin Invest (1987) 1.45
Genetic factors in non-syndromic congenital heart malformations. Clin Genet (2010) 1.43
Sex-specific genetic effects influence variation in body composition. Diabetologia (2008) 1.43
A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet (1994) 1.43
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG (2016) 1.41
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet (2005) 1.40
A physical and transcriptional map of the preaxial polydactyly locus on chromosome 7q36. Genomics (1999) 1.40
Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet (2001) 1.40
Platelet-derived growth factor is angiogenic in vivo. Growth Factors (1992) 1.40